Welcome to this, the first 2024 issue of touchREVIEWS in RMD! This issue features a dynamic collection of articles highlighting the ever evolving landscape in rheumatic and musculoskeletal disorders. This issue features editorials, reviews and a case report exploring the latest in rheumatic diseases, rheumatoid arthritis, systemic lupus erythematosus, paediatric rheumatology and vasculitis.
We would like to thank all who those contributed towards this edition, in particular our authors, Editor-in-Chief, editorial board members and partners.
We are now welcoming submissions to our 2024/2025 editions. If you’re interested in submitting an article, please get in touch.
Foreword – touchREVIEWS in RMD, Volume 3, Issue 1, 2024
Welcome to the latest edition of touchREVIEWS in RMD! We’re excited to share a dynamic collection of articles that highlight the evolving landscape of rheumatic and musculoskeletal diseases (RMDs). We open the issue by delving into a series of editorials offering expert insights and critical analyses on recent developments and key issues in the field. […]
Clinical Approach to Periodic Inflammation of Unknown Origin in Adults, with a Focus on the Diagnosis of Systemic Autoinflammatory Diseases
This editorial outlines a clinical approach to patients with periodic inflammation of unknown origin despite initial rational and targeted investigation. The focus of the editorial is on the recognition and diagnosis of systemic autoinflammatory diseases (SAIDs). Although rare, SAIDs are valuable diagnoses given they carry a risk of disease-associated damage and are often treatable. The authors […]
The Role of Non-pharmacological Management in Systemic Lupus Erythematosus and Systemic Sclerosis: A Summary of the EULAR Recommendations
Systemic lupus erythematosus (SLE) predominantly affects females and is characterized by multisystem involvement.1,2 Despite advancements in therapeutics, patients with SLE still experience poor health-related quality of life (HRQoL).3 Systemic sclerosis (SSc) is characterized by vasculopathy and fibrosis of the skin and visceral organs.4 Like SLE, SSc contributes to a high morbidity burden and negatively impacts patients’ HRQoL.4 Non-pharmacological […]
Multiomics Studies in Rheumatoid Arthritis: The Search for the Holy Grail of Predicting Treatment Response
Although biological disease-modifying antirheumatic drugs (bDMARDs) are significantly cheaper now that biosimilar agents are available, they still represent a significant cost to health services worldwide, particularly since their prescription has only increased since the thresholds for commencing this treatment have been lowered. For example, in 2017/8, the total cost of adalimumab to the NHS in England […]
CAR T Cell Therapy: A New Hope for Refractory Lupus?
Systemic lupus erythematosus (SLE) is a multisystem, autoimmune disorder affecting skin, joints, kidneys, the heart, lungs, the brain and blood cells, and is characterized by heterogeneous presentations and severity. It is more common in females than males, with a ratio of 9:1, and it is associated with significant morbidity and mortality.1 Despite recent novel therapies […]
Navigating Comorbidities in Chronic Inflammatory Rheumatic Diseases: Insight and Strategies
The global burden of disease is heavily impacted by the increased prevalence of chronic inflammatory rheumatic diseases (CIRDs [rheumatoid arthritis (RA), spondyloarthritis (SpA), connective tissue diseases (CTDs) crystal arthropathies and polyarticular osteoarthritis (OA)]), which are prevalent chronic non-communicable diseases associated with pain, functional impairment, and years lived with disability (YLDs).1–4 Comorbidities associated with CIRDs contribute […]
A Viewpoint on Therapeutic Approaches and Unmet Needs in the Management of Young People with Sjӧgren Disease
It is increasingly recognized that autoimmune rheumatic diseases (ARDs) can affect people of any age, starting from early childhood and continuing until later in life. Furthermore, in recent decades, it has become apparent that Sjögren disease (SjD), commonly diagnosed in women aged 35–50 years old, can also affect men of all ages, as well as […]
Lane–Hamilton Syndrome: A Vasculitis Mimic Presenting with Diffuse Alveolar Haemorrhage and Positive ANCA Testing
Diffuse alveolar haemorrhage (DAH) is associated with high morbidity and mortality. The causes of DAH are diverse, and include rheumatologic conditions such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), Systemic lupus erythematosus (SLE) and Goodpasture’s syndrome (Table 1). Rheumatologists are frequently consulted, given the high degree of suspicion for these underlying aetiologies. Another possible […]
Erratum to Correct Informed Patient Consent Statement
This corrects the article: “Gheriani GA, Tuetken R and Lenert P. Lane–Hamilton Syndrome: A Vasculitis Mimic Presenting with Diffuse Alveolar Haemorrhage and Positive ANCA Testing. touchREVIEWS in RMD. 2024;3(1):37–42” The patient consent statement was added incorrectly due to an editorial error. The correct patient informed consent statement, provided by the authors, is included below. “Written […]